Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
SPECIFIC STUDY AIMS
1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer.
2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.
Stanford is currently not accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Men that will undergo prostate radiotherapy as a primary treatment or
post-prostatectomy.
- Age 18 or older
- Ability to understand and sign informed consent
Exclusion Criteria:
- Younger than 18 yrs old
- Inability to provide written and spoken consent.
- Patients with implanted actively controlled devices that may be subject to
electromagnetic interference from the UroNav/PervuNav electromagnetic tracking used in
the study.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Male
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
CCTO
650-498-7061
Not Recruiting
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.
